Literature DB >> 17334631

Enhanced mast cell chymase expression in human idiopathic interstitial pneumonia.

Kazuto Hirata1, Yoshimi Sugama, Yoshihiro Ikura, Masahiko Ohsawa, Yoshikazu Inoue, Satoru Yamamoto, Masanori Kitaichi, Makiko Ueda.   

Abstract

Previous studies have shown that mast cell chymase induces and promotes fibrogenesis in injured tissues. We studied the roles of mast cell chymase in the fibritic processes of human idiopathic interstitial pneumonias. Frozen tissue sections from human lungs with usual interstitial pneumonia (n=7), nonspecific interstitial pneumonia (n=4) and normal lungs (n=10) were studied immunohistochemically. Monoclonal antibodies against mast cell chymase, tryptase, interleukin-4, and smooth muscle actin were used. Stained cells or areas were quantified by computer-aided morphometry. The numbers of both tryptase-positive mast cells and chymase-positive mast cells were significantly greater in lung tissues with idiopathic interstitial pneumonia than in normal lung tissues. The increase in the number of chymase-positive mast cells in the diseased lung tissues was closely related to an increase in interleukin-4-positive cells, and also to an accumulation of smooth muscle cells and myofibroblasts. Because smooth muscle cell and myofibroblast proliferation is a principal pathological change in idiopathic interstitial pneumonias, these observations suggest that mast cell chymase, possibly induced by interleukin-4-dependent phenotypic modulation, may be an important mediator in the inflammatory and fibrotic processes of idiopathic interstitial pneumonia in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334631

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Differential mast cell numbers and characteristics in human tuberculosis pulmonary lesions.

Authors:  Karen Magdalena Garcia-Rodriguez; Estela Isabel Bini; Armando Gamboa-Domínguez; Clara Inés Espitia-Pinzón; Sara Huerta-Yepez; Silvia Bulfone-Paus; Rogelio Hernández-Pando
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

2.  Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Authors:  Cecilia K Andersson; Annika Andersson-Sjöland; Michiko Mori; Oskar Hallgren; Annie Pardo; Leif Eriksson; Leif Bjermer; Claes-Göran Löfdahl; Moises Selman; Gunilla Westergren-Thorsson; Jonas S Erjefält
Journal:  Respir Res       Date:  2011-10-20

3.  Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis.

Authors:  Johanna Salonen; Mervi Kreus; Siri Lehtonen; Hannu Vähänikkilä; Minna Purokivi; Riitta Kaarteenaho
Journal:  Inflammation       Date:  2021-10-22       Impact factor: 4.092

4.  Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.

Authors:  Alessio Filippo Peritore; Ramona D'Amico; Rosalba Siracusa; Marika Cordaro; Roberta Fusco; Enrico Gugliandolo; Tiziana Genovese; Rosalia Crupi; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

5.  CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells.

Authors:  Elena P Moiseeva; Katy M Roach; Mark L Leyland; Peter Bradding
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.